Cargando…

The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4(+)Foxp3(+) Regulatory T Cells

There is now compelling evidence that tumor necrosis factor (TNF) preferentially activates and expands CD4(+)Foxp3(+) regulatory T cells (Tregs) through TNF receptor type II (TNFR2). However, it remains unclear which signaling transduction pathway(s) of TNFR2 is required for the stimulation of Tregs...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Tianzhen, Liu, Shuoyang, Chen, Shaokui, Ye, Jingyi, Wu, Xueqiang, Bian, Zhaoxiang, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046375/ https://www.ncbi.nlm.nih.gov/pubmed/30038619 http://dx.doi.org/10.3389/fimmu.2018.01556

Ejemplares similares

The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
por: Shi, Qinghai, et al.
Publicado: (2015)

In vitro modeling of COPD inflammation and limitation of p38 inhibitor – SB203580
por: Meng, Aihong, et al.
Publicado: (2016)

SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma
por: Paw, Milena, et al.
Publicado: (2021)

Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells
por: Han, Xiaolu, et al.
Publicado: (2018)

SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation
por: Sreekanth, Gopinathan Pillai, et al.
Publicado: (2016)

Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats
por: Sanit, Jantira, et al.
Publicado: (2019)

A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190
por: Glover, Mark, et al.
Publicado: (2010)

Peripheral Injection of SB203580 Inhibits the Inflammatory-Dependent Synthesis of Proinflammatory Cytokines in the Hypothalamus
por: Herman, Andrzej P., et al.
Publicado: (2014)

SB203580 increases G-CSF production via a stem-loop destabilizing element in the 3’ untranslated region in macrophages independently of its effect on p38 MAPK activity
por: Chang, Shwu-Fen, et al.
Publicado: (2016)

SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen‐activated protein kinase in olfactory sensory neuronal apoptosis of OVA‐induced allergic rhinitis)
por: Gao, Xian, et al.
Publicado: (2019)

Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis
por: Gao, Bo, et al.
Publicado: (2016)

Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer
por: Abdolvand, Maryam, et al.
Publicado: (2023)

Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4(+)Foxp3(+) Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice
por: Chen, Shaokui, et al.
Publicado: (2022)

Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4(+)Foxp3(+) regulatory T cells
por: He, Tianzhen, et al.
Publicado: (2020)

Cyclophosphamide abrogates the expansion of CD4(+)Foxp3(+) regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
por: Li, Ping, et al.
Publicado: (2021)

Phenotype expansion of variants affecting p38 MAPK signaling in hypospadias patients
por: Lin, Defu, et al.
Publicado: (2022)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus
por: Kim, Ji-Eun, et al.
Publicado: (2020)

Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
por: M.Gaspal, Fabrina, et al.
Publicado: (2011)

Protective Effects of p38 MAPK Inhibitor SB202190 against Hippocampal Apoptosis and Spatial Learning and Memory Deficits in a Rat Model of Vascular Dementia
por: Yang, Shen, et al.
Publicado: (2013)

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity
Publicado: (1989)

p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy
por: Escós, Alejandra, et al.
Publicado: (2016)

Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro
por: Dhandapani, Hemavathi, et al.
Publicado: (2021)

Monascin abrogates RANKL-mediated osteoclastogenesis in RAW264.7 cells via regulating MAPKs signaling pathways
por: Cheng, Yin, et al.
Publicado: (2022)

Apelin protects against ischemia-reperfusion injury in diabetic myocardium via inhibiting apoptosis and oxidative stress through PI3K and p38-MAPK signaling pathways
por: An, Songtao, et al.
Publicado: (2020)

p38 MAPK Signaling in Osteoblast Differentiation
por: Rodríguez-Carballo, Eddie, et al.
Publicado: (2016)

p38 MAPK in cardioprotection – are we there yet?
por: Martin, E D, et al.
Publicado: (2015)

P38 MAPK and Radiotherapy: Foes or Friends?
por: García-Flores, Natalia, et al.
Publicado: (2023)

New Insights into the p38γ and p38δ MAPK Pathways
por: Risco, Ana, et al.
Publicado: (2012)

On the decay of 110Sb, 111Sb, 112Sb, 113Sb and 114Sb
por: Sunier, J W, et al.
Publicado: (1970)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation
por: Kong, Xiangying, et al.
Publicado: (2015)

Absence of Leucine Zipper in the Natural FOXP3Δ2Δ7 Isoform Does Not Affect Dimerization but Abrogates Suppressive Capacity
por: Mailer, Reiner K. W., et al.
Publicado: (2009)

p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease
por: Qi, Xiao-Mei, et al.
Publicado: (2023)

Tumor necrosis factor α modulates sodium-activated potassium channel SLICK in rat dorsal horn neurons via p38 MAPK activation pathway
por: Wang, Kun, et al.
Publicado: (2017)

Rh–Sb Nanoclusters: Synthesis, Structure, and Electrochemical Studies of the Atomically Precise [Rh(20)Sb(3)(CO)(36)](3–) and [Rh(21)Sb(2)(CO)(38)](5–) Carbonyl Compounds
por: Femoni, Cristina, et al.
Publicado: (2020)

Correction to: Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation
por: Kong, Xiangying, et al.
Publicado: (2021)

The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
por: Wang, Shuman, et al.
Publicado: (2021)

p38MAPK Signaling Pathway in Osteoarthritis: Pathological and Therapeutic Aspects
por: Li, Zongchao, et al.
Publicado: (2022)

p38 MAPK, microglial signaling, and neuropathic pain
por: Ji, Ru-Rong, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_16aieki50r2p9aeq3cu1nue086